Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia

Physiology and Behavior

Volumn 92, Issue 3, 2007, Pages 461-467

  Ahnaou, A ^a   Nayak, S ^a   Heylen, A ^a   Ashton, D ^a   Drinkenburg, W H I M ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

EEG; Hippocampus lesion; Rat; Schizophrenia; Sleep

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; FEMALE; HIPPOCAMPUS; LOCOMOTION; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SLEEP; SLEEP DISORDER; SLEEP PATTERN;

EID: 35248855910     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.04.020     Document Type: Article

References (51)

1. Zarcone V.P.J., Benson K.L., and Berger P.A. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry 44 (1987) 45-48
2. Haffmans P.M., Hoencamp E., Knegtering H.J., and Van Heycop ten Ham B.F. Sleep disturbance in schizophrenia. Br J Psychiatry 165 (1994) 697-698
3. Lauer C.J., Schreiber W., Polltaker T., Holsboer F., and Krieg J.C. Sleep in schizophrenia: a polysomnographic study on drug-naive patients. Neuropsychopharmacology 16 (1997) 51-60
4. Hiatt J.F., Floyd T.C., Katz P.H., and Feinberg I. Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia. Arch Gen Psychiatry 42 (1985) 797-802
5. Monti J.M., and Monti D. Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8 (2004) 133-148
6. Miyauchi T., Tanaka K., Hagimoto H., Miura T., Kishimoto H., and Matsushita M. Computerized EEG in schizophrenia patients. Biol Psychiatry 28 (1990) 488-494
7. Elbert T., Lutzenberger W., Rockstroh B., Berg P., and Cohen R. Physical aspects of the EEG in schizophrenia. Biol Psychiatry 32 (1992) 595-606
8. Sponheim S.R., Clementz B.A., Iacono W.G., and Beiser M. Resting EEG in first episode and chronic schizophrenia. Psychophysiology 31 (1994) 37-43
9. Wuebben Y., and Winterer G. Hypofrontality: a risk marker related to schizophrenia?. Schizophr Res 48 (2001) 207-217
10. Sponheim S.R., Clementz B.A., Iacono W.G., and Beiser M. Clinical and biological concomitants of resting state EEG power abnormalities in schizophrenia. Biol Psychiatry 48 (2000) 1088-1097
11. Günther W., Breitling D., Banquet J., Marcie P., and Rondot P. EEG mapping of left hemisphere dysfunction during motor performance in schizophrenia. Biol Psychiatry 21 (1986) 249-262
12. Knott V., Labelle A., Jones B., and Mahoney C. Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment. Schizophr Res 50 (2001) 41-53
13. Merrin E., Fein G., Floyd T., and Yingling C. EEG asymmetry in schizophrenic patients before and during neuroleptic treatment. Biol Psychiatry 21 (1986) 455-464
14. Williamson P., and Mamelak M. Frontal spectral EEG findings in acutely ill schizophrenics. Biol Psychiatry 22 (1987) 1021-1024
15. Takeuchi K., Takigawa M., Fukuzako H., Hokazono Y., Hirakawa K., and Fukuzako T. Correlation of the third ventricle enlargement and EEG slow wave activity in schizophrenia patients. Psychiatr Res 55 (1994) 1-11
16. Karson C.N., Coppola R., and Daniel D.G. Alpha frequency in schizophrenia: an association with enlarged cerebral ventricle. Am J Psychiatry 33 (1988) 284-290
17. Alper K., Gunther W., Prichepp L.S., John E.R., and Brodie J. Correlation of q EEG with PET in schizophrenia. Neuropsychobiology 38 (1998) 0-56
18. Kemali D., Maj M., Galderisi S., Ariano M.G., and Starace F. Factors associated with increased noradrenaline levels in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 14 (1990) 49-59
19. Morihisa J.M., Duffy F.H., and Wyatt R.J. Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiatry 40 (1983) 719-728
20. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
21. Yamamoto J. Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine. Psychopharmacology 131 (1991) 379-387
22. Becker A., Grecksch G., Bernstein H.G., Hollt V., and Bogerts B. Social behavior in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology 144 (1999) 333-338
23. Deacon R.M.J., Croucher A., and Rawlins J.N.P. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res 132 (2002) 203-213
24. Lipska B.K., and Weinberger D.R. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci U S A 92 (1995) 8906-8910
25. Lipska B.K., Halim N.D., Segal P.N., and Weiberger D.R. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22 (2002) 2835-2842
26. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
27. Lipska B.K., Al-Amin H.A., and Weinberger D.R. Excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 19 (1998) 451-464
28. Lipska B.K., Jaskiw G.E., and Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9 (1993) 67-75
29. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, San Diego, USA
30. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev 3 (2000) 251-269
31. Grace A.A. Gating information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 31 (2000) 330-341
32. Gray J.A. In: Gazzaniga M.S. (Ed). A model of limbic system and basal ganglia applications to anxiety and schizophrenia. The cognitive neurosciences (1995), MIT Press, Cambridge, Mass 1165-1176
33. Bachevalier J., Alvarado M.C., and Malkova L. Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood. Biol Psychiatry 46 (1999) 329-339
34. Swerdlow N.R., Halim N., Hanlon F.M., Platten A., and Auerbach P.P. Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less. Brain Res Bull 55 (2001) 71-77
35. Vanderwolf C.H., Raithby A., Snide M., Cristi C., and Tanner C. Effects of some cholinergic agonists on neocortical slow wave activity in rats with basal forebrain lesions. Brain Res Bull 31 (1993) 515-521
36. Bast T., Zhang W.N., and Feldon T. Hyperactivity decreased startle reactivity and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABA(A) receptor antagonist picrotoxin. Psychopharmacology 156 (2001) 225-233
37. Pace-Schott E.F., and Hobson J.A. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3 (2002) 679-693
38. Tandon R., and Greden J.F. Cholinergic hyperactivity and negative schizophrenic symptoms: a model of cholinergic/dopaminergic interactions in schizophrenia. Arch Gen Psychiatry 46 (1989) 745-753
39. Thaker G.K., Wagman A.M.I., and Tamminga C.A. Sleep polygraphy in schizophrenia: methodological issues. Biol Psychiatry 28 (1990) 240-246
40. Lee M.G., Chrobak J.J., Sik A., Wiley R.G., and Buzsaki G. Hippocampal theta activity following selective lesion of the septal cholinergic system. Neuroscience 62 (1994) 1033-1047
41. Begic E.D., Hotujac L.J., and Jokic-Begic N. Quantitative EEG in 'positive' and 'negative' schizophrenia. Acta Psychiatr Scand 101 (2000) 307-311
42. Détári L., Rasmuson D.D., and Semba K. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog Neurobiol 58 (1999) 249-277
43. Semba K. The cholinergic basal forebrain: a critical role in cortical arousal. Adv Exp Med Biol 295 (1991) 197-218
44. Van Groen T., and Lopes da Silva F.H. Organization of the reciprocal connections between the subiculum and the enthorinal cortex in the cat: II an electrophysiological study. J Comp Neurol 251 (1986) 111-120
45. Stewart D.J., MacFabe D.F., and Vanderwolf C.H. Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate. Brain Res 322 (1984) 219-232
46. Ugedo L., Grenhoff J., and Svensson T.H. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98 (1989) 45-50
47. Knott V., Harr A., and Ilivistsky V. EEG correlates of acute nicotinic and muscarinic cholinergic blockade: separate and combined administration of scopolamine and mecamylamine in normal human subjects. Hum Psychopharmacol 12 (1997) 573-582
48. Goldstein J., Litwin L., Sutton E., and Malick J. Effects of ICI 169369, a selective serotonin 2 antagonist in electrophysiological tests predictive of antipsychotic activity. J Pharmacol Exp Ther 249 (1989) 673-680
49. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase 67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57 (2000) 237-245
50. Ray P.G., and Jackson W.J. Lesions of the nucleus basalis alters ChAT activity and EEG in rat frontal cortex. Electroencephalogr Clin Neurophysiol 79 (1991) 62-68
51. McCarley R.W., Faux S.F., Shenton M.E., Nestor P.G., and Adams J. Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathology. Schizophr Res 4 (1991) 209-231